Aculys Pharma, Inc. announces the appointment of Hidemasa Tanigaki as Chief Executive Officer and Representative Director, effective March 29th.
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO Read More »
3M completed the planned spin-off of its health care business, which formally launches Solventum Corporation as an independent company.
Foresee Pharmaceuticals, announces the positive safety review by the independent Data and Safety Monitoring Board for its Casppian Phase 3 registration study.
Avery Dennison Corporation will host its first quarter 2024 earnings conference call in a live webcast at 12:00 p.m. ET on Wednesday, April 24, 2024.
Avery Dennison to Webcast First Quarter 2024 Earnings Conference Call Read More »
Merck, known as MSD outside of the United States and Canada, will hold its first-quarter 2024 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, April 25.
Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25 Read More »
Learn about a few of the many ways AI tools are helping to transform healthcare — and how they benefit physicians and patients along the way.
Los también conocidos como levantadores hidráulicos de válvula o taqués de válvula hidráulica, son piezas que forman parte de los componentes esenciales en el tren de válvulas de cualquier motor de un vehículo de combustión int …
Qué son y para qué sirven los taqués hidráulicos Read More »
To safeguard M&A activity, CISOs and security teams must have a seat at the table to implement proper IT visibility.
Ready or not: How healthcare infrastructure can brace for 5G acceleration Read More »
La administración remota de sistemas, como un servicio externalizado, ha ganado una gran importancia en el panorama empresarial actual, especialmente entre las grandes empresas, donde las infraestructuras pueden llegar a ser realmente complejas y su gestión requiere de expert …
Administración remota de sistemas: un servicio externalizado en auge Read More »
Nxera Pharma Co., Ltd. is pleased to announce the launch of its new company name, having received approval at the 34th Ordinary General Meeting of Shareholders held on 27 March 2024.
